Skip to main content
TipRanks
Go Ultimate75% OFF

Tenaya Therapeutics (TNYA) Ratios

3,507 Followers

Tenaya Therapeutics Ratios

TNYA's free cash flow for Q3 2026 was $1.56M. For the 2026 fiscal year, TNYA's free cash flow was increased by $11.00K and operating cash flow was $-17.68M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio6.844.224.917.9911.73
Quick Ratio6.844.224.917.9911.73
Cash Ratio6.510.272.013.931.75
Solvency Ratio-3.47-3.79-3.71-3.23-1.80
Operating Cash Flow Ratio-4.42-5.67-4.49-4.31-2.79
Short-Term Operating Cash Flow Coverage0.00-32.580.000.00-30.50
Net Current Asset Value$ 81.93M$ 40.29M$ 80.49M$ 158.19M$ 217.24M
Leverage Ratios
Debt-to-Assets Ratio0.070.110.070.050.05
Debt-to-Equity Ratio0.090.150.090.060.06
Debt-to-Capital Ratio0.080.130.080.060.05
Long-Term Debt-to-Capital Ratio0.060.000.000.000.00
Financial Leverage Ratio1.191.291.221.151.14
Debt Service Coverage Ratio0.00-36.960.000.00-34.45
Interest Coverage Ratio0.000.000.000.000.00
Debt to Market Cap0.070.020.000.000.00
Interest Debt Per Share0.070.160.170.340.38
Net Debt to EBITDA1.09-0.090.290.700.33
Profitability Margins
Gross Profit Margin0.00%0.00%0.00%0.00%0.00%
EBIT Margin0.00%0.00%0.00%0.00%0.00%
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
Operating Profit Margin0.00%0.00%0.00%0.00%0.00%
Pretax Profit Margin0.00%0.00%0.00%0.00%0.00%
Net Profit Margin0.00%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin0.00%0.00%0.00%0.00%0.00%
Net Income Per EBT100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT97.07%95.84%94.58%98.44%99.88%
Return on Assets (ROA)-61.66%-92.65%-72.77%-44.33%-22.97%
Return on Equity (ROE)-73.50%-119.68%-89.00%-50.81%-26.11%
Return on Capital Employed (ROCE)-70.98%-111.53%-88.77%-49.32%-24.69%
Return on Invested Capital (ROIC)-69.39%-108.62%-86.25%-48.56%-24.52%
Return on Tangible Assets-61.66%-92.65%-72.77%-44.33%-22.97%
Earnings Yield-83.24%-91.62%-51.90%-137.26%-9.29%
Efficiency Ratios
Receivables Turnover0.000.000.000.000.00
Payables Turnover2.361.641.540.910.38
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover0.000.000.000.000.00
Asset Turnover0.000.000.000.000.00
Working Capital Turnover Ratio0.000.000.000.000.00
Cash Conversion Cycle-154.94-222.50-236.55-401.24-972.21
Days of Sales Outstanding0.000.000.000.000.00
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding154.94222.50236.55401.24972.21
Operating Cycle0.000.000.000.000.00
Cash Flow Ratios
Operating Cash Flow Per Share-0.45-1.07-1.38-2.33-1.47
Free Cash Flow Per Share-0.45-1.08-1.40-2.79-2.08
Dividend Paid and CapEx Coverage Ratio-110.46-88.29-82.38-5.06-2.42
Capital Expenditure Coverage Ratio-110.46-88.29-82.38-5.06-2.42
Operating Cash Flow Coverage Ratio-6.30-6.65-8.22-6.92-3.87
Operating Cash Flow to Sales Ratio0.000.000.000.000.00
Free Cash Flow Yield-63.29%-75.46%-43.21%-138.80%-10.98%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-1.21-1.09-1.93-0.73-10.76
Price-to-Sales (P/S) Ratio0.000.000.000.000.00
Price-to-Book (P/B) Ratio0.881.311.710.372.81
Price-to-Free Cash Flow (P/FCF) Ratio-1.58-1.33-2.31-0.72-9.11
Price-to-Operating Cash Flow Ratio-1.59-1.34-2.34-0.86-12.87
Price-to-Earnings Growth (PEG) Ratio0.020.050.05-0.01-0.13
Enterprise Value Multiple-0.23-1.27-1.78-0.09-11.06
Enterprise Value19.12M130.58M205.81M9.92M760.04M
EV to EBITDA-0.23-1.27-1.78-0.09-11.06
EV to Sales0.000.000.000.000.00
EV to Free Cash Flow-0.28-1.43-1.99-0.08-8.84
EV to Operating Cash Flow-0.28-1.44-2.02-0.10-12.50
Tangible Book Value Per Share0.811.091.895.436.75
Shareholders’ Equity Per Share0.811.091.895.436.75
Tax and Other Ratios
Effective Tax Rate0.000.000.000.000.00
Revenue Per Share0.000.000.000.000.00
Net Income Per Share-0.59-1.31-1.68-2.76-1.76
Tax Burden1.001.001.001.001.00
Interest Burden1.001.001.001.001.00
Research & Development to Revenue0.000.000.000.000.00
SG&A to Revenue0.000.000.000.000.00
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality0.750.810.820.840.84

Currency in USD